4.7 Article

The Disposition Index Does Not Reflect β-Cell Function in IGT Subjects Treated With Pioglitazone

期刊

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 99, 期 10, 页码 3774-3781

出版社

ENDOCRINE SOC
DOI: 10.1210/jc.2014-1515

关键词

-

资金

  1. Takeda Pharmaceuticals North America

向作者/读者索取更多资源

Aims and Hypothesis: The insulin secretion/insulin resistance (IR) (disposition) index (Delta I/Delta G divided by IR, where Delta is change from baseline, I is insulin, and G is glucose) is commonly used as a measure of beta-cell function. This relationship is curvilinear and becomes linear when log transformed. Delta I is determined by 2 variables: insulin secretion rate (ISR) and metabolic clearance of insulin. We postulated that the characteristic curvilinear relationship would be lost if Delta plasma C-peptide (Delta CP) (instead of Delta plasma insulin) was plotted against insulin sensitivity. Methods: A total of 441 individuals with impaired glucose tolerance (IGT) from ACT NOW received an oral glucose tolerance test and were randomized to pioglitazone or placebo for 2.4 years. Results: Pioglitazone reduced IGT conversion to diabetes by 72% (P <.0001). Delta I/Delta G vs the Matsuda index of insulin sensitivity showed the characteristic curvilinear relationship. However, when Delta CP/Delta G or Delta ISR/Delta G was plotted against the Matsuda index, the curvilinear relationship was completely lost. This discordance was explained by 2 distinct physiologic effects that altered plasma insulin response in opposite directions: 1) increased ISR and 2) augmented metabolic clearance of insulin. The net result was a decline in the plasma insulin response to hyperglycemia during the oral glucose tolerance test. These findings demonstrate a physiologic control mechanism wherein the increase in ISR ensures adequate insulin delivery into the portal circulation to suppress hepatic glucose production while delivering a reduced but sufficient amount of insulin to peripheral tissues to maintain the pioglitazone-mediated improvement in insulin sensitivity without excessive hyperinsulinemia. Conclusions: These results demonstrate the validity of the disposition index when relating the plasma insulin response to insulin sensitivity but underscore the pitfall of this index when drawing conclusions about beta-cell function, because insulin secretion declined despite an increase in the plasma insulin response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Medicine, General & Internal

Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis

Sara Guerra, Gabriele Mocciaro, Amalia Gastaldelli

Summary: Non-alcoholic fatty liver disease (NAFLD) and its more severe form NASH are common complications in patients with obesity and type 2 diabetes. Understanding the pathogenesis and factors influencing the development of fatty liver disease can help in early identification and prevention of these serious conditions.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Cardiac & Cardiovascular Systems

Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study

Cecilia Vecoli, Giuseppina Basta, Andrea Borghini, Melania Gaggini, Serena Del Turco, Antonella Mercuri, Amalia Gastaldelli, Maria Grazia Andreassi

Summary: This study found that high levels of sRAGE and short LTL were associated with an increased risk of major adverse cardiovascular events (MACEs) in patients with coronary artery disease (CAD), particularly in patients with diabetes.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Article Medicine, General & Internal

Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease

Angelo Armandi, Chiara Rosso, Aurora Nicolosi, Gian Paolo Caviglia, Maria Lorena Abate, Antonella Olivero, Daphne D'Amato, Marta Vernero, Melania Gaggini, Giorgio Maria Saracco, Davide Giuseppe Ribaldone, Diana Julie Leeming, Amalia Gastaldelli, Elisabetta Bugianesi

Summary: This study found that circulating irisin levels in non-diabetic, non-obese patients with NAFLD are associated with fibrosis and severity of liver damage.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases

Fabrizia Carli, Demetrio Ciociaro, Amalia Gastaldelli

Summary: Exposomics analysis emphasizes the importance of biomonitoring human exposure to pollutants, especially for endocrine and cardiometabolic diseases associated with phthalates and BPA. Therefore, biomonitoring of exposure to these compounds is needed in both childhood and adulthood.

METABOLITES (2022)

Article Endocrinology & Metabolism

Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects

Christopher E. Shannon, Aurora Merovci, Marcel Fourcaudot, Devjit Tripathy, Muhammad Abdul-Ghani, Hu Wang, Xianlin Han, Luke Norton, Ralph A. DeFronzo

Summary: This study demonstrates that the major lipid pools in skeletal muscle are not affected by increased glucose availability, suggesting that glucotoxicity and lipotoxicity promote insulin resistance through distinct mechanistic pathways.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Biochemistry & Molecular Biology

Altered Insulin Clearance after Gastric Bypass and Sleeve Gastrectomy in the Fasting and Prandial Conditions

Marzieh Salehi, Ralph DeFronzo, Amalia Gastaldelli

Summary: This study investigated the effect of weight loss surgery on insulin kinetics. The results showed that the altered insulin clearance rate after surgery is mainly attributed to the liver rather than other organs. In addition, the endogenous insulin clearance rate is more sensitive to the increase in circulating insulin levels, while peripheral insulin sensitivity is similar among the three groups. After a meal, the weight loss surgery group had higher insulin secretion, independent of glycemic levels. Compared to sleeve gastrectomy, gastric bypass surgery resulted in greater post-meal insulin secretion and a reduction in post-meal insulin clearance rate.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Gastroenterology & Hepatology

Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals

Chiara Saponaro, Silvia Sabatini, Melania Gaggini, Fabrizia Carli, Chiara Rosso, Vincenzo Positano, Angelo Armandi, Gian Paolo Caviglia, Riccardo Faletti, Elisabetta Bugianesi, Amalia Gastaldelli

Summary: This study investigates the association between visceral fat and subcutaneous fat with the severity of NAFLD, suggesting that visceral fat accumulation is a major risk factor for NAFLD.

LIVER INTERNATIONAL (2022)

Review Endocrinology & Metabolism

Measuring and estimating insulin resistance in clinical and research settings

Amalia Gastaldelli

Summary: The article discusses different methodologies to measure insulin resistance in muscle, liver, and adipose tissue in human participants, ranging from gold standard tests to surrogate indices based on fasting measurements or dynamic tests.

OBESITY (2022)

Article Endocrinology & Metabolism

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

Alexander J. Moody, Marjorie Molina-Wilkins, Geoffrey D. Clarke, Aurora Merovci, Carolina Solis-Herrera, Eugenio Cersosimo, Robert J. Chilton, Patricia Iozzo, Amalia Gastaldelli, Muhammad Abdul-Ghani, Ralph A. DeFronzo

Summary: This study aimed to investigate the effects of pioglitazone on epicardial and paracardial adipose tissue, as well as diastolic function and insulin sensitivity in patients with type 2 diabetes mellitus. The results showed that pioglitazone reduced the areas of epicardial and paracardial adipose tissue, improved left ventricular diastolic function, and increased insulin sensitivity.

DIABETES OBESITY & METABOLISM (2023)

Editorial Material Endocrinology & Metabolism

Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

Egeria Scoditti, Giulio Marchesini, Amalia Gastaldelli

DIABETES CARE (2023)

Editorial Material Biochemistry & Molecular Biology

Role of Insulin Clearance in Insulin Action and Metabolic Diseases

Hilda E. Ghadieh, Amalia Gastaldelli, Sonia M. Najjar

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk

Fabrizia Carli, Silvia Sabatini, Melania Gaggini, Anna Maria Sironi, Giorgio Bedogni, Amalia Gastaldelli

Summary: This study found that a fatty liver index (FLI) greater than 60 is associated with a high risk of metabolic dysfunction-associated steatotic liver disease (MASLD), diabetes, and cardiovascular disease. FLI was also positively associated with cardiac fat, visceral fat, and components of metabolic syndrome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Gastroenterology & Hepatology

Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives

Aleksander Krag, Maria Buti, Jeffrey Lazarus, Alina M. Allen, Jacqueline Bowman, Patrizia Burra, Giacomo Donnini, Ajay Duseja, Manal H. El-Sayed, Amalia Gastaldelli, Ben Hainsworth, Tom H. Karlsen, Michael Kessler, Marko Korenjak, Henry E. Mark, Jake P. Mann, Veronica Miller, Mario G. Pessoa, Daniel Pineiro, Shiv K. Sarin, Shivaram P. Singh, Mary E. Rinella, Jose Willemse, Zobair M. Younossi, Sven M. Francque

JOURNAL OF HEPATOLOGY (2023)

Review Medicine, General & Internal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

Wayne Eskridge, Donna R. Cryer, Joern M. Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M. Allen, Mazen Noureddin, Arun J. Sanyal

Summary: Diagnosing and managing MASLD is a major challenge in primary care due to lack of agreement on diagnostic tools, difficulty in identifying symptoms and their cause, absence of approved pharmacological treatments, and limited awareness of the disease. Prompt diagnosis and management are critical to preventing MASLD from progressing to more severe liver disease. Raising awareness and improving understanding of MASLD among both patients and physicians is crucial.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study

Athina I. Amanatidou, Eleni V. Mikropoulou, Charalampia Amerikanou, Maja Milanovic, Stefan Stojanoski, Mladen Bjelan, Lucia Cesarini, Jonica Campolo, Anastasia Thanopoulou, Rajarshi Banerjee, Mary Jo Kurth, Natasa Milic, Milica Medic-Stojanoska, Maria Giovanna Trivella, Sophie Visvikis-Siest, Amalia Gastaldelli, Maria Halabalaki, Andriana C. Kaliora, George V. Dedoussis

Summary: This study aimed to investigate the relationship between MRI parameters reflecting inflammation and fibrosis and plasma amino acid (AA) concentrations in NAFLD patients. The study found that subjects with higher MRI-proton density fat fraction (MRI-PDFF) had higher plasma AA levels compared to those with lower PDFF. Significant associations were also observed between AAs and MRI-PDFF and MRI-cT1, suggesting the potential utility of circulating AAs as diagnostic markers for NAFLD.

METABOLITES (2023)

暂无数据